. . . . . . . . . "\"FOSAMAX is contraindicated in patients with the following conditions: Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see Warnings and Precautions (5.1) Inability to stand or sit upright for at least 30 minutes [see Dosage and Administration (2.6) Warnings and Precautions (5.1) Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. Hypocalcemia [see Warnings and Precautions (5.2) Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported [see Adverse Reactions (6.2) Abnormalities of the esophagus which delay emptying such as stricture or achalasia ( 4 5.1 Inability to stand/sit upright for at least 30 minutes ( 2.6 4 5.1 Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. ( 4 Hypocalcemia ( 4 5.2 Hypersensitivity to any component of this product ( 4 6.2\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "IeCuS7sJs8ZrSUHIlcK5Bs6pGrLjszoFbikvxCH2+AEl3OdS96G1p96FX+BTVm3yIGY/xM+GfGA0PwVUKi25fvhXOfE5z9PrcedEfefiFCjKp+/YTZ+7dVIEcUB0ZQEp3r5GvWmQTm9kA5jjFziqYXmmlGQYEdZyl5yRDe6izkY=" . . "2021-08-23T13:03:35.050+02:00"^^ . . . . .